Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Practice-level variation in use of recommended medications among outpatients with heart failure: Insights from the NCDR PINNACLE program.

Peterson PN, Chan PS, Spertus JA, Tang F, Jones PG, Ezekowitz JA, Allen LA, Masoudi FA, Maddox TM.

Circ Heart Fail. 2013 Nov;6(6):1132-8. doi: 10.1161/CIRCHEARTFAILURE.113.000163. Epub 2013 Oct 15.

2.

Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.

Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Gheorghiade M, Inge PJ, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.

Circ Heart Fail. 2010 Sep;3(5):596-605. doi: 10.1161/CIRCHEARTFAILURE.109.912683. Epub 2010 Jul 15.

3.

Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR (National Cardiovascular Data Registry).

Maddox TM, Chan PS, Spertus JA, Tang F, Jones P, Ho PM, Bradley SM, Tsai TT, Bhatt DL, Peterson PN.

J Am Coll Cardiol. 2014 Feb 18;63(6):539-46. doi: 10.1016/j.jacc.2013.09.053. Epub 2013 Oct 30.

4.

Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.

Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.

Am Heart J. 2009 Apr;157(4):754-62.e2. doi: 10.1016/j.ahj.2008.12.016.

PMID:
19332206
5.

Association between performance measures and clinical outcomes for patients hospitalized with heart failure.

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy C, Young JB; OPTIMIZE-HF Investigators and Hospitals.

JAMA. 2007 Jan 3;297(1):61-70.

PMID:
17200476
6.

Treatment differences by health insurance among outpatients with coronary artery disease: insights from the national cardiovascular data registry.

Smolderen KG, Spertus JA, Tang F, Oetgen W, Borden WB, Ting HH, Chan PS.

J Am Coll Cardiol. 2013 Mar 12;61(10):1069-75. doi: 10.1016/j.jacc.2012.11.058. Epub 2013 Jan 30.

7.

Appropriateness of Prescriptions of Recommended Treatments in Organisation for Economic Co-operation and Development Health Systems: Findings Based on the Long-Term Registry of the European Society of Cardiology on Heart Failure.

Maggioni AP, Van Gool K, Biondi N, Urso R, Klazinga N, Ferrari R, Maniadakis N, Tavazzi L.

Value Health. 2015 Dec;18(8):1098-104. doi: 10.1016/j.jval.2015.08.005. Epub 2015 Sep 14.

PMID:
26686796
8.

Outpatient management of heart failure in the United States, 2006-2008.

Mosalpuria K, Agarwal SK, Yaemsiri S, Pierre-Louis B, Saba S, Alvarez R, Russell SD.

Tex Heart Inst J. 2014 Jun 1;41(3):253-61. doi: 10.14503/THIJ-12-2947. eCollection 2014 Jun.

9.

Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program.

Bainey KR, Armstrong PW, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Zhao X, Schwamm LH, Bhatt DL.

Circ Cardiovasc Qual Outcomes. 2014 Mar;7(2):227-35. doi: 10.1161/CIRCOUTCOMES.113.000422. Epub 2014 Feb 25.

10.

Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.

Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP; REACH Investigators.

Crit Pathw Cardiol. 2009 Sep;8(3):104-11. doi: 10.1097/HPC.0b013e3181b8395d.

PMID:
19726929
11.

Use of guideline-recommended therapies for heart failure in the Medicare population.

DiMartino LD, Shea AM, Hernandez AF, Curtis LH.

Clin Cardiol. 2010 Jul;33(7):400-5. doi: 10.1002/clc.20760.

12.

Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.

Maggioni AP, Anker SD, Dahlström U, Filippatos G, Ponikowski P, Zannad F, Amir O, Chioncel O, Leiro MC, Drozdz J, Erglis A, Fazlibegovic E, Fonseca C, Fruhwald F, Gatzov P, Goncalvesova E, Hassanein M, Hradec J, Kavoliuniene A, Lainscak M, Logeart D, Merkely B, Metra M, Persson H, Seferovic P, Temizhan A, Tousoulis D, Tavazzi L; Heart Failure Association of the ESC.

Eur J Heart Fail. 2013 Oct;15(10):1173-84. doi: 10.1093/eurjhf/hft134. Epub 2013 Aug 26.

13.

Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.

Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J.

Am Heart J. 2004 Jul;148(1):43-51.

PMID:
15215791
14.

Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.

Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M; French National College of Cardiologists.

Arch Cardiovasc Dis. 2012 Jun-Jul;105(6-7):355-65. doi: 10.1016/j.acvd.2012.04.003. Epub 2012 Jun 28.

15.

Evaluation of the management of heart failure in primary care.

Calvert MJ, Shankar A, McManus RJ, Ryan R, Freemantle N.

Fam Pract. 2009 Apr;26(2):145-53. doi: 10.1093/fampra/cmn105. Epub 2009 Jan 18.

16.

Treatment of heart failure in real-world clinical practice: findings from the REFLECT-HF registry in patients with NYHA class II symptoms and a reduced ejection fraction.

Böhm M, Tschöpe C, Wirtz JH, Lokies J, Turgonyi E, Bramlage P, Lins K, Strunz AM, Tebbe U.

Clin Cardiol. 2015 Apr;38(4):200-7. doi: 10.1002/clc.22375. Epub 2015 Mar 2.

17.

The impact of patient-specific quality-of-care report cards on guideline adherence in heart failure.

Matthews JC, Johnson ML, Koelling TM.

Am Heart J. 2007 Dec;154(6):1174-83. Epub 2007 Oct 24.

PMID:
18035092
18.

Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey.

de Groote P, Isnard R, Assyag P, Clerson P, Ducardonnet A, Galinier M, Jondeau G, Leurs I, Thébaut JF, Komajda M.

Eur J Heart Fail. 2007 Dec;9(12):1205-11.

19.

Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.

Güder G, Störk S, Gelbrich G, Brenner S, Deubner N, Morbach C, Wallenborn J, Berliner D, Ertl G, Angermann CE.

Eur J Heart Fail. 2015 Apr;17(4):442-52. doi: 10.1002/ejhf.252. Epub 2015 Mar 2.

20.

B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF.

Ambrosy AP, Fonarow GC, Albert NM, Curtis AB, Heywood JT, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Gheorghiade M.

J Cardiovasc Med (Hagerstown). 2012 Jun;13(6):360-7. doi: 10.2459/JCM.0b013e328353128c.

PMID:
22472850
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk